Edition:
United States

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

20.55USD
20 Jul 2018
Change (% chg)

$0.20 (+0.98%)
Prev Close
$20.35
Open
$20.28
Day's High
$20.55
Day's Low
$20.05
Volume
2,482
Avg. Vol
3,516
52-wk High
$27.44
52-wk Low
$7.35

Chart for

About

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The... (more)

Overall

Beta: 2.28
Market Cap(Mil.): $152.57
Shares Outstanding(Mil.): 7.50
Dividend: --
Yield (%): --

Financials

  ACER.OQ Industry Sector
P/E (TTM): -- 217.69 33.34
EPS (TTM): -1.21 -- --
ROI: -165.82 -3.65 13.18
ROE: -165.82 -5.62 15.09

BRIEF-Acer Therapeutics Q4 Loss Per Share $0.63

* ACER THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 07 2018

Competitors

Earnings vs. Estimates